Latest updates for Abx:ca
Fresh curated links around ABX:CA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Barrick Mining: Robust Fundamentals, IPOs Planned, A Buy
- ABIVAX Société Anonyme (ABVX) Discusses Positive Phase III ABTECT Trial Results for Obefazimod in Ulcerative Colitis - S
- Is ABIVAX Société Anonyme (ABVX) A Good Stock To Buy Now?
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
ABIVAX Société Anonyme (ABVX) Discusses Positive Phase III ABTECT Trial Results for Obefazimod in Ulcerative Colitis - S...
TMX Group Limited (X:CA) RAFI Indices, LLC, - M&A Call - Slideshow
AbraSilver: RIGI Turns Diablillos Into A Scarce Silver Development Asset
ABIVAX Société Anonyme (ABVX) Discusses ABTECT Maintenance Part 2 Results and Updated Obefazimod Safety and Efficacy Dat...
Abivax: Downgrading To 'Hold' As NDA Obefazimod Still Underway Despite Major Safety Risks
AbCellera Biologics Inc. (ABCL) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Atea Pharmaceuticals: I'm Optimistic Ahead Of Critical HPV Catalyst
Absci Corporation (ABSI) Presents at Jefferies Global Healthcare Conference 2026 - Slideshow
Abivax Grounded as Cancer Cases Cast a Shadow Over Best-in-Class Trial Data
XCF Global Terminates Equity Purchase Agreement, Reducing Potential Dilution and Market Overhang
Approximately 55 million shares previously reserved for issuance are no longer reservedReduced related potential dilution and associated market overhangCompany retains flexibility...
Bicara Therapeutics Inc. (BCAX) Discusses New Clinical Data on Investigational Therapy for HPV Negative Head and Neck Ca...
StockWatch: New UC Data Sparks Smoother Sailing for Abivax
Less than a month after its stock roller-coastered on safety signals associated with its late-stage ulcerative colitis (UC) drug candidate obefazimod, shares of Abivax (Euronext Pa...
ImmunityBio: Could Be One Approval Away From A Multi-Billion Dollar Breakout
XOMA Royalty shareholders approve incentive plan amendments and bylaw changes
Abivax stock reverses course, trades down 40% despite positive ulcerative colitis trial
StockWatch: Abivax Survives a Roller Coaster Week
Abivax’s stock plummeted after analysts from Jefferies, Morgan Stanley, Truist Securities, and Wedbush Securities raised as a safety concern a portion of data showing malignancies...
American Bitcoin Corp. 2026 Q1 - Results - Earnings Call Presentation
Aura Minerals board approves up to $200M share and BDRs buyback program
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.